https://www.selleckchem.com/products/c25-140.html
e findings contribute to a growing body of evidence on the importance of treatment continuity for OUD and support the validity of measuring continuity in provider-level accountability programs. To examine longitudinal neurocognitive decline among Latino, non-Latino Black, and non-Latino White people with HIV (PWH) and factors that may explain ethnic/racial disparities in neurocognitive decline. Four hundred ninety nine PWH (13.8% Latino, 42.7% Black, 43.5% White; baseline age M = 43.5) from the CNS HIV Anti-Retroviral Therapy Effects Re
Like
Comment
Share
